Serum concentration and protein binding of thioridazine and its metabolites in patients with chronic alcoholism
- PMID: 7173306
- DOI: 10.1007/BF00613621
Serum concentration and protein binding of thioridazine and its metabolites in patients with chronic alcoholism
Abstract
The blood chemistry and clinical pharmacokinetics of thioridazine and its metabolites, side-chain sulphoxide, side-chain sulphone and ring sulphoxide, were studied in 31 alcoholics and were compared with values in 17 thioridazine-treated controls without alcoholism. Pathological blood chemistry values, including abnormal liver function and protein concentrations, were common among the alcoholics. In relation to dosage, the majority had a low serum concentration of thioridazine and at a given concentration of thioridazine they had high serum concentrations of its metabolites. Positive intercorrelations were found between pathological liver function tests, prolonged serum half-life and increased serum concentration of thioridazine. The free fractions of thioridazine, side-chain sulphoxide and ring sulphoxide were significantly higher and those of the side-chain sulphone lower in the alcoholics than in the controls. The free fractions of side-chain and ring sulphoxide were significantly increased in patients with a low concentration of alpha 1-acid glycoprotein.
Similar articles
-
Binding of thioridazine and thioridazine metabolites to serum proteins. An in vitro study.Naunyn Schmiedebergs Arch Pharmacol. 1982 Jun;319(3):189-96. doi: 10.1007/BF00495864. Naunyn Schmiedebergs Arch Pharmacol. 1982. PMID: 7110380
-
Plasma levels of thioridazine and metabolites are influenced by the debrisoquin hydroxylation phenotype.Clin Pharmacol Ther. 1991 Mar;49(3):234-40. doi: 10.1038/clpt.1991.22. Clin Pharmacol Ther. 1991. PMID: 2007317 Clinical Trial.
-
Unbound plasma concentrations, total plasma concentrations, and red blood cell concentrations of thioridazine and its main metabolites: an in vitro study.Naunyn Schmiedebergs Arch Pharmacol. 1987 Apr;335(4):465-8. doi: 10.1007/BF00165564. Naunyn Schmiedebergs Arch Pharmacol. 1987. PMID: 3600822
-
Sulphoxide metabolites of thioridazine in man.Xenobiotica. 1986 Dec;16(12):1097-107. doi: 10.3109/00498258609038987. Xenobiotica. 1986. PMID: 3798957
-
Thioridazine and its metabolites in post mortem blood, including two stereoisomeric ring sulfoxides.J Anal Toxicol. 1982 Sep-Oct;6(5):250-2. doi: 10.1093/jat/6.5.250. J Anal Toxicol. 1982. PMID: 7176556
Cited by
-
Thioridazine induces apoptosis by targeting the PI3K/Akt/mTOR pathway in cervical and endometrial cancer cells.Apoptosis. 2012 Sep;17(9):989-97. doi: 10.1007/s10495-012-0717-2. Apoptosis. 2012. PMID: 22460505 Free PMC article.
-
Binding of thioridazine and thioridazine metabolites to serum proteins. An in vitro study.Naunyn Schmiedebergs Arch Pharmacol. 1982 Jun;319(3):189-96. doi: 10.1007/BF00495864. Naunyn Schmiedebergs Arch Pharmacol. 1982. PMID: 7110380
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical